Literature DB >> 28201666

The ascending rank of chronic kidney disease in the global burden of disease study.

Kitty J Jager1, Simon D S Fraser2.   

Abstract

General population-based studies, the chronic kidney disease (CKD) prognosis consortium and renal registries worldwide have contributed to the description of the scale of CKD as a public health problem. Since 1990, CKD has been included in the list of non-communicable diseases investigated by the Global Burden of Disease (GBD) study. The GBD represents a systematic, high-quality, scientific effort to quantify the comparative magnitude of health loss from all major diseases, injuries and risk factors. This article provides an outline of the place of CKD in the ranking of these diseases and the change over time. Whereas age-standardized death and disability-adjusted life years (DALYs) rates due to non-communicable diseases in general have been declining, such favourable trends do not exist for CKD. Altogether the GBD reports indicate increasing rates for death and DALYs due to CKD with huge variation across the globe. A substantial component of the observed increase in mortality attributable to CKD relates to that caused by diabetes mellitus and hypertension. For the increase in DALYs, CKD due to diabetes mellitus appears to be the main contributor. It is possible that these trends are in part due to new data becoming available or different coding behaviour over time, including greater specificity of coding. Although some feel there is evidence of overdiagnosis, it seems clear that in many regions CKD and its risk factors are a growing public health problem and in some of them rank very high as cause of years of life lost and DALYs. Therefore, public health policies to address this problem as well as secondary prevention in high-risk groups remain greatly needed.
© The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  CKD; death rates; disability-adjusted life years; prevalence; years of life lost

Mesh:

Year:  2017        PMID: 28201666     DOI: 10.1093/ndt/gfw330

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  49 in total

1.  Interoperability of Electronic Health Information and Care of Dialysis Patients in the United States.

Authors:  Paul R Sutton; Thomas H Payne
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-06       Impact factor: 8.237

2.  Multiplex Serum Biomarker Assays Improve Prediction of Renal and Mortality Outcomes in Chronic Kidney Disease.

Authors:  William P Martin; Chloe Conroy; Serika D Naicker; Sarah Cormican; Tomás P Griffin; Md Nahidul Islam; Eibhlin M McCole; Ivan McConnell; John Lamont; Peter FitzGerald; John P Ferguson; Ciarán Richardson; Susan E Logue; Matthew D Griffin
Journal:  Kidney360       Date:  2021-05-21

3.  Secular Changes in Mortality and Hospitalization over Time in People with Kidney Failure or Severe CKD as Compared with Other Noncommunicable Diseases.

Authors:  Marcello Tonelli; Natasha Wiebe; Matthew T James; Scott W Klarenbach; Braden J Manns; Neesh Pannu; Pietro Ravani; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2020-09-29       Impact factor: 14.978

4.  AGING-ASSOCIATED COGNITIVE DECLINE IS REVERSED BY D-SERINE SUPPLEMENTATION.

Authors:  L Nava-Gómez; I Calero-Vargas; F Higinio-Rodríguez; B Vázquez-Prieto; R Olivares-Moreno; J Ortiz-Retana; P Aranda; N Hernández-Chan; G Rojas-Piloni; S Alcauter; M López-Hidalgo
Journal:  eNeuro       Date:  2022-05-18

Review 5.  Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes.

Authors:  Roberto Pecoits-Filho; Ikechi G Okpechi; Jo-Ann Donner; David C H Harris; Harith M Aljubori; Aminu K Bello; Ezequiel Bellorin-Font; Fergus J Caskey; Allan Collins; Alfonso M Cueto-Manzano; John Feehally; Bak Leong Goh; Kitty J Jager; Masaomi Nangaku; Muhibur Rahman; Manisha Sahay; Abdulkarim Saleh; Laura Sola; Rumeyza Turan Kazancioglu; Rachael C Walker; Robert Walker; Qiang Yao; Xueqing Yu; Ming-Hui Zhao; David W Johnson
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

6.  Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

Review 7.  Step-by-step guide to setting up a kidney replacement therapy registry: the challenge of a national kidney replacement therapy registry.

Authors:  Guillermo Rosa-Diez; María Carlota González-Bedat; Rosario Luxardo; María Laura Ceretta; Alejandro Ferreiro-Fuentes
Journal:  Clin Kidney J       Date:  2021-01-24

8.  Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys.

Authors:  Lin Xu; Bo Tan; Di Huang; Meijie Yuan; Tingting Li; Ming Wu; Chaoyang Ye
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

9.  The Association Between Dietary Inflammatory Index and Parathyroid Hormone in Adults With/Without Chronic Kidney Disease.

Authors:  Zheng Qin; Qinbo Yang; Ruoxi Liao; Baihai Su
Journal:  Front Nutr       Date:  2021-06-25

10.  Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019.

Authors:  Yujiao Deng; Na Li; Ying Wu; Meng Wang; Si Yang; Yi Zheng; Xinyue Deng; Dong Xiang; Yuyao Zhu; Peng Xu; Zhen Zhai; Dai Zhang; Zhijun Dai; Jie Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.